Fingerprint
Dive into the research topics of 'The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy
M. V. Blagosklonny, T. Fojo, K. N. Bhalla, J. S. Kim, J. B. Trepel, W. D. Figg, Y. Rivera, L. M. Neckers
Research output: Contribution to journal › Article › peer-review
129
Scopus
citations